ERAD Therapeutics Inc., an Orphan Disease company focussing on Gaucher Disease and Cystic Fibrosis by delivering protein therapeutics to all cells in the body, including the central nervous system,.will be presenting its abstract entitled "PROKARYOTIC ERAD BLOCKADE CORRECTS F508DEL CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) DEPENDENT SALIVA SECRETION IN CYSTIC FIBROSIS (CF) MICE."at the ICCF 2018: International Conference on Cystic Fibrosis, May 14-16 in London UK.
